Pictet Asset Management (Switzerland)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$123M Buy
2023
Q1
$121M Buy
2022
Q4
$105M Sell
2022
Q3
$135M Sell
2022
Q2
$99.3M Buy
2022
Q1
$108M Buy
2021
Q4
$104M Sell
2021
Q3
$156M Buy